Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hodgkin Disease × Goserelin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 138 Breast Neoplasms 94 Neoplasms 8 Neoplasm Metastasis 6 Breast Neoplasms, Male 6 Salivary Gland Neoplasms 3 Prostate Adenocarcinoma 3 Advanced Breast Cancer 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Osteoporosis 2 Leiomyoma 2 Infertility 2 Advanced Prostate Cancer 2 Stage I Prostate Adenocarcinoma AJCC v7 1 Sexual Dysfunction, Physiological 1 Sarcopenia 1 Radiation Injuries 1 Primary Ovarian Insufficiency 1 Primary Dysautonomias 1 Patients With T1-4 Advanced Prostate Cancer 1 Patient Compliance 1 PSA Level Greater Than Two 1 Ovarian Neoplasms 1 Osteitis Deformans 1 Myofibroma 1 Lymphatic Metastasis 1 Kidney Diseases 1 Inflammatory Breast Neoplasms 1 Hypertension 1

Interventions

Cyclophosphamide 192 fludarabine phosphate 122 Peripheral Blood Stem Cell Transplantation 107 Etoposide 106 Mycophenolic Acid 94 Filgrastim 92 Doxorubicin 84 Whole-Body Irradiation 83 Tacrolimus 80 Brentuximab Vedotin 80 Melphalan 78 Radiotherapy 74 Busulfan 74 fludarabine 67 Cyclosporine 66 Vinblastine 64 Rituximab 60 Dacarbazine 55 Granulocyte Colony-Stimulating Factor 53 Gemcitabine 52 Antilymphocyte Serum 51 Bleomycin 50 Methotrexate 47 Vincristine 46 Prednisone 45 Nivolumab 45 Cytarabine 44 Carmustine 36 pembrolizumab 35 Bendamustine Hydrochloride 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01014507 2012-06-25

PROFE

University of Cologne

Phase 2 Completed

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡